Literature DB >> 19194660

ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr.

John Overington.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19194660     DOI: 10.1007/s10822-009-9260-9

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


× No keyword cloud information.
  4 in total

Review 1.  Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics.

Authors:  Christoph Steinbeck; Christian Hoppe; Stefan Kuhn; Matteo Floris; Rajarshi Guha; Egon L Willighagen
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 2.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

Review 3.  Genomic-scale prioritization of drug targets: the TDR Targets database.

Authors:  Fernán Agüero; Bissan Al-Lazikani; Martin Aslett; Matthew Berriman; Frederick S Buckner; Robert K Campbell; Santiago Carmona; Ian M Carruthers; A W Edith Chan; Feng Chen; Gregory J Crowther; Maria A Doyle; Christiane Hertz-Fowler; Andrew L Hopkins; Gregg McAllister; Solomon Nwaka; John P Overington; Arnab Pain; Gaia V Paolini; Ursula Pieper; Stuart A Ralph; Aaron Riechers; David S Roos; Andrej Sali; Dhanasekaran Shanmugam; Takashi Suzuki; Wesley C Van Voorhis; Christophe L M J Verlinde
Journal:  Nat Rev Drug Discov       Date:  2008-10-17       Impact factor: 84.694

4.  The Chemistry Development Kit (CDK): an open-source Java library for Chemo- and Bioinformatics.

Authors:  Christoph Steinbeck; Yongquan Han; Stefan Kuhn; Oliver Horlacher; Edgar Luttmann; Egon Willighagen
Journal:  J Chem Inf Comput Sci       Date:  2003 Mar-Apr
  4 in total
  57 in total

1.  Can we really do computer-aided drug design?

Authors:  Matthew Segall
Journal:  J Comput Aided Mol Des       Date:  2011-12-11       Impact factor: 3.686

2.  IUPHAR-DB: an open-access, expert-curated resource for receptor and ion channel research.

Authors:  Joanna L Sharman; Chidochangu P Mpamhanga
Journal:  ACS Chem Neurosci       Date:  2011-05-18       Impact factor: 4.418

Review 3.  PubChem as a public resource for drug discovery.

Authors:  Qingliang Li; Tiejun Cheng; Yanli Wang; Stephen H Bryant
Journal:  Drug Discov Today       Date:  2010-10-21       Impact factor: 7.851

4.  The Recognition of Identical Ligands by Unrelated Proteins.

Authors:  Sarah Barelier; Teague Sterling; Matthew J O'Meara; Brian K Shoichet
Journal:  ACS Chem Biol       Date:  2015-10-12       Impact factor: 5.100

5.  Crystal structure-based virtual screening for fragment-like ligands of the human histamine H(1) receptor.

Authors:  Chris de Graaf; Albert J Kooistra; Henry F Vischer; Vsevolod Katritch; Martien Kuijer; Mitsunori Shiroishi; So Iwata; Tatsuro Shimamura; Raymond C Stevens; Iwan J P de Esch; Rob Leurs
Journal:  J Med Chem       Date:  2011-11-07       Impact factor: 7.446

6.  Reactome pathway analysis to enrich biological discovery in proteomics data sets.

Authors:  Robin Haw; Henning Hermjakob; Peter D'Eustachio; Lincoln Stein
Journal:  Proteomics       Date:  2011-09       Impact factor: 3.984

Review 7.  Exploring chemical space for drug discovery using the chemical universe database.

Authors:  Jean-Louis Reymond; Mahendra Awale
Journal:  ACS Chem Neurosci       Date:  2012-04-25       Impact factor: 4.418

8.  Fragment-based in silico modeling of multi-target inhibitors against breast cancer-related proteins.

Authors:  Alejandro Speck-Planche; M Natália D S Cordeiro
Journal:  Mol Divers       Date:  2017-02-13       Impact factor: 2.943

9.  The ChEMBL database as linked open data.

Authors:  Egon L Willighagen; Andra Waagmeester; Ola Spjuth; Peter Ansell; Antony J Williams; Valery Tkachenko; Janna Hastings; Bin Chen; David J Wild
Journal:  J Cheminform       Date:  2013-05-08       Impact factor: 5.514

10.  Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.

Authors:  Aditya J Desai; Polo C H Lam; Andrew Orry; Ruben Abagyan; Arthur Christopoulos; Patrick M Sexton; Laurence J Miller
Journal:  J Med Chem       Date:  2015-12-10       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.